Pulmonary Thromboembolism After Revision Total Knee Arthroplasty: A Report of Two Cases
Article Sidebar
Main Article Content
Abstract
Two female patients (74 and 80 years old) underwent revision total knee arthroplasty surgery due to aseptic loosening. Patient 1 was obese, while patient 2 had history of abdominal surgery, cerebrovascular and autoimmune disease. They were both under anti-depressive medication. Intravenous tranexamic acid was administrated according to institutional protocol. Knee mobilization and enoxaparin in prophylactic dose was initiated at day 1 postoperatively. Both patients had pulmonary thromboembolism within the first 30 days after surgery. Individual risk factors predispose to pulmonary thromboembolism, while tranexamic acid way of administration does not seem to be responsible for the risk increase.
Individual risk factors predispose to pulmonary thromboembolism, while tranexamic acid way of administration does not seem to be responsible for the risk increase.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their articles and grant the journal the right of first publication under the Creative Commons Attribution (CC BY) license, which allows others to share and adapt the work with proper attribution.
References
Warren JA, et al. Venous thromboembolism rates did not decrease in lower extremity revision total joint arthroplasty from 2008 to 2016. J Arthroplasty. 2019 Nov;34(11):2774–2779. doi:10.1016/j.arth.2019.05.012.
Sharkey PF, Lichstein PM, Shen C, Tokarski AT, Parvizi J. Why are total knee arthroplasties failing today—has anything changed after 10 years? J Arthroplasty. 2013 Apr;29(9):1774–1778. doi:10.1016/j.arth.2013.07.024.
Shahi A, Bradbury TL, Guild GN, Saleh UH, Ghanem E, Oliashirazi A. What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients? Arthroplast Today. 2018 Sep;4(3):343–347. doi:10.1016/j.artd.2018.02.014.
Tate JP, Padley JH, Banerjee S, Schneider AM, Brown NM. An analysis of risk factors for venous thromboembolism in primary versus revision total joint arthroplasty. J Clin Orthop Trauma. 2023 Nov;46:102296. doi:10.1016/j.jcot.2023.102296.
Ponzio DY, Austin MS. Metaphyseal bone loss in revision knee arthroplasty. Curr Rev Musculoskelet Med. 2015 Dec;8(4):361–367. doi:10.1007/s12178-015-9291-x.
Bohl DD, Samuel AM, Basques BA, Della Valle CJ, Levine BR, Grauer JN. How much do adverse event rates differ between primary and revision total joint arthroplasty? J Arthroplasty. 2016 Mar;31(3):596–602. doi:10.1016/j.arth.2015.09.033.
Saleh KJ, Hoeffel DP, Kassim RA, Burstein G. Complications after revision total knee arthroplasty. J Bone Joint Surg Am. 2003;85-A Suppl 1:S71–S74.
Shin YS, Yoon JR, Lee HN, Park SH, Lee DH. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2017 Nov;25(11):3585–3595. doi:10.1007/s00167-016-4235-6.
Tian P, Liu WB, Li ZJ, Xu GJ, Huang YT, Ma XL. The efficacy and safety of tranexamic acid in revision total knee arthroplasty: a meta-analysis. BMC Musculoskelet Disord. 2017 Jun;18(1):273. doi:10.1186/s12891-017-1633-y.
Boylan MR, Perfetti DC, Kapadia BH, Delanois RE, Paulino CB, Mont MA. Venous thromboembolic disease in revision vs primary total knee arthroplasty. J Arthroplasty. 2017 Jun;32(6):1996–1999. doi:10.1016/j.arth.2016.12.051.
Parvizi J, Huang R, Raphael IJ, Arnold WV, Rothman RH. Symptomatic pulmonary embolus after joint arthroplasty: strati-fication of risk factors. Clin Orthop Relat Res. 2014 Mar;472(3):903–912. doi:10.1007/s11999-013-3358-z.
Porto JR, Lavu MS, Hecht CJ, Asimakis OG, Kaelber DC, Kamath AF. Tranexamic acid lowers transfusions and readmissions in high-risk total knee arthroplasty patients, but neurologic risks remain in patients with seizures or visual disturbances. Knee Surg Sports Traumatol Arthrosc. 2025. doi:10.1002/ksa.70124.